QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=AE4F7F7AAFC4068E9F3136CFBA2A254B;jsessionid=081E2E86E96080529C92C4FB5785CA02;jsessionid=7116CFF2C305E39B6A5ADB16A592939D;jsessionid=0B3561E72662FBE6EB77424C6CF9E852;jsessionid=48FD400854722EAA9233B97BBB9A4283;jsessionid=60238739B2F34634A15F586986642293;jsessionid=6144F063B2F5DD43A1EEF5065A9004B5;jsessionid=57872C0CCA2005B7659353D1C23AA51E;jsessionid=F43CD8BC323B00525B3ADAC817B7FB77;jsessionid=D734CA2B11C5B12ECE51EF80957DDDA5;jsessionid=3BDE9DC68EA7F83FB6771CECBCE46A1D;jsessionid=F62AD5F9B829BAD19FF9A67EAF195368;jsessionid=8D4DEF34F11C2A7B5820A949CDC843F8;jsessionid=0E52720503315D06977B0E2877C7C904 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. A Case of Coexistent Spinocerebellar Ataxia Type 2 and Primary Progressive Multiple Sclerosis-Coinci…
4. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
5. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=AE4F7F7AAFC4068E9F3136CFBA2A254B;jsessionid=081E2E86E96080529C92C4FB5785CA02;jsessionid=7116CFF2C305E39B6A5ADB16A592939D;jsessionid=0B3561E72662FBE6EB77424C6CF9E852;jsessionid=48FD400854722EAA9233B97BBB9A4283;jsessionid=60238739B2F34634A15F586986642293;jsessionid=6144F063B2F5DD43A1EEF5065A9004B5;jsessionid=57872C0CCA2005B7659353D1C23AA51E;jsessionid=F43CD8BC323B00525B3ADAC817B7FB77;jsessionid=D734CA2B11C5B12ECE51EF80957DDDA5;jsessionid=3BDE9DC68EA7F83FB6771CECBCE46A1D;jsessionid=F62AD5F9B829BAD19FF9A67EAF195368;jsessionid=8D4DEF34F11C2A7B5820A949CDC843F8;jsessionid=0E52720503315D06977B0E2877C7C904